Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: A randomized controlled trial

Molecular Autism

Volumn 3, Issue 1, 2012, Pages

  Anagnostou, Evdokia ^a,b   Soorya, Latha ^a,e   Chaplin, William ^c   Bartz, Jennifer ^a   Halpern, Danielle ^a   Wasserman, Stacey ^a   Wang, A Ting ^a   Pepa, Lauren ^a   Tanel, Nadia ^b   Kushki, Azadeh ^b   Hollander, Eric ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b University of Toronto   (Canada)

^c ST JOHN'S UNIVERSITY   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e RUSH UNIVERSITY   (United States)

Author keywords

Adults; Autism; Clinical trial; Oxytocin; Social cognition

Indexed keywords

OXYTOCIN; PLACEBO;

ADULT; ARTICLE; AUTISM; COGNITION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REPETITIVE BEHAVIOR SCALE REVISED; SINGLE DRUG DOSE; SOCIAL STATUS;

ANIMALIA;

EID: 84872107494     PISSN: None     EISSN: 20402392     Source Type: Journal    
DOI: 10.1186/2040-2392-3-16     Document Type: Article

References (38)

1. Prosocial effects of oxytocin strand clinical evidence for its therapeutic potential. Striepens N, Kendrick KM, Maier W, Hurlemann R, Front Neuroendocrinol 2011 32 426 450 10.1016/j.yfrne.2011.07.001 21802441
2. A 9-year-old male with a duplication of chromosome 3p25.3p26.2: clinical report and gene expression analysis. Bittel DC, Kibiryeva N, Dasouki M, Knoll JH, Butler MG, Am J Med Genet 2006 140 573 579 16470700
3. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. Gregory S, Connelly JJ, Towers AJ, Johnson J, Biscocho D, Markunas CA, Lintas C, Abramson KA, Wright HH, Ellis P, Langford CF, Worley G, Delong GR, Murphy SK, Cuccaro ML, Persico A, Pericak-Vance M, BMC Med 2009 7 62 10.1186/1741-7015-7-62 19845972
4. Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism. Jacob S, Brune CW, Carter CS, Leventhal BL, Lord C, Cook EH, Neurosci Lett 2007 417 6 9 10.1016/j.neulet.2007.02.001 17383819
5. Strong association of de novo copy number mutations with autism. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B, Yoon S, Krasnitz A, Kendall J, Leotta A, Pai D, Zhang R, Lee YH, Kicks J, Spence SJ, Lee AT, Puura K, Lehtimäki T, Ledbetter D, Gregersen PK, Bregman J, Sutcliffe JS, Jobanputra V, Chung W, Warburton D, King MC, Skuse D, Geschwind DH, Gilliam TC, Ye K, Wigler M, Science 2007 316 445 449 10.1126/science.1138659 17363630
6. Promoting social behavior with oxytocin in high functioning autism spectrum disorders. Andari E, Duhamel J, Zalla T, Herbrecht E, Leboyer M, Sirigu A, Proc Natl Acad Sci U S A 2010 107 4389 4394 10.1073/pnas.0910249107 20160081
7. Oxytocin and autistic disorder: alteration in peptide forms. Green LA, Fein D, Modahl C, Feinstein C, Waterhouse L, Morris M, Biol Psychiatry 2001 50 609 613 10.1016/S0006-3223(01)01139-8 11690596
8. Plasma oxytocin levels in autistic children. Modahl C, Green LA, Fein D, Morris M, Waterhouse L, Feinstein C, Levin H, Biol Psychiatry 1998 43 270 277 10.1016/S0006-3223(97)00439-3 9513736
9. Neuroendocrine perspectives on social attachment and love. Carter CS, Psychoneuroendocrinology 1998 23 779 818 10.1016/S0306-4530(98)00055-9 9924738
10. Oxytocin, vasopressin, and autism: is there a connection. Insel TR, Obrien DJ, Leckman JF, Biol Psychiatry 1999 45 145 157 10.1016/S0006-3223(98) 00142-5 9951561
11. Social amnesia in mice lacking the oxytocin gene. Ferguson JN, Young LJ, Hearn EF, Matzuk MM, Insel TR, Winslow JT, Nat Genet 2000 25 284 288 10.1038/77040 10888874
12. Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice. Takayanagi Y, Yoshida M, Bielsky IF, Ross H, Kawamata M, Onaka T, Yanagisawa T, Kimura T, Matzuk M, Young LJ, Nishimori K, Pfaff DW, Proc Natl Acad Sci U S A 2005 102 16096 16101 10.1073/pnas.0505312102 16249339
13. Pharmacological rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Sala M, Braida D, Lentini D, Busnelli M, Bulgheroni E, Capurro V, Finardi A, Donzelli A, Pattini L, Rubino T, Parolaro D, Nishimori K, Parenti M, Chini B, Biol Psychiatry 2011 69 875 882 10.1016/j.biopsych.2010.12.022 21306704
14. Oxytocin increases trust in humans. Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E, Nature 2005 435 673 676 10.1038/nature03701 15931222
15. Oxytocin modulates neural circuitry for social cognition and fear in humans. Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S, Gruppe H, Mattay VS, Gallhofer B, Meyer-Lindenberg A, J Neurosci 2005 25 11489 11493 10.1523/JNEUROSCI.3984-05.2005 16339042
16. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Domes G, Heinrichs M, Gläscher J, Büchel C, Braus DF, Herpertz SC, Biol Psychiatry 2007 62 1187 1190 10.1016/j.biopsych.2007.03.025 17617382
17. Oxytocin improves 'mind-reading' in humans. Domes G, Heinrichs M, Michel A, Berger C, Herpertz SC, Biol Psychiatry 2006 61 731 733 17137561
18. Oxytocin increases gaze to the eye region of human faces. Guastella AJ, Mitchell PB, Dadds MR, Biol Psychiatry 2007 63 3 5 17888410
19. Post-learning intranasal oxytocin modulates human memory for facial identity. Savaskan E, Ehrhardt R, Schulz A, Walter M, Schachinger H, Psychoneuroendocrinology 2008 33 368 374 10.1016/j.psyneuen.2007.12.004 18221838
20. Oxytocin makes a face memory familiar. Rimelle U, Hediger K, Heinrichs M, Klaver P, J Neurosci 2009 29 38 42 10.1523/JNEUROSCI.4260-08.2009 19129382
21. Oxytocin increases retention of social cognition in autism. Hollander E, Bartz J, Chaplin W, Phillips A, Sumner J, Soorya L, Anagnostou E, Wasserman S, Biol Psychiatry 2007 61 498 503 10.1016/j.biopsych.2006.05.030 16904652
22. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR, Mosovich S, Neuropsychopharmacology 2003 28 193 198 10.1038/sj.npp.1300021 12496956
23. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Guastella A, Einfeld S, Gray K, Rinehart N, Tonge B, Lambert TJ, Hickie IB, Biol Psychiatry 2009 67 692 694 19897177
24. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. Lord C, Risi S, Lambrecht L, Cook EH, Leventhal BL, DiLavore PC, Pickles A, Rutter M, J Autism Dev Disord 2000 30 205 223 10.1023/A:1005592401947 11055457
25. Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Lord C, Rutter M, Le Couteur A, J Autism Dev Disord 1994 24 659 685 10.1007/BF02172145 7814313
26. The Yale-brown obsessive compulsive scale. I. Development, use, and reliability. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS, Arch Gen Psychiat 1989 46 1006 1011 10.1001/archpsyc.1989.01810110048007 2684084
27. Varieties of repetitive behavior in autism: comparisons to mental retardation. Bodfish JW, Symons FJ, Parker DE, Lewis MH, J Autism Dev Disord 2000 30 237 243 10.1023/A:1005596502855 11055459
28. Constantino JN, The Social Responsiveness Scale Los Angeles, CA: Western Psychological Services 2002
29. The 'Reading the Mind in the Eyes' test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism. Baron-Cohen S, Wheelwright S, Hill J, Raste Y, Plumb I, J Child Psychol Psychiatry 2001 42 241 251 10.1111/1469-7610.00715 11280420
30. Perception of emotion: measuring decoding accuracy of adult prosodic cues varying in intensity. Baum KM, Nowicki S, J Nonverbal Behav 1989 22 89 107
31. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Skevington SM, Lotfy M, O'Connell KA, Qual Life Res 2004 13 299 310 15085902
32. Brief report: repetitive behaviors in Greek individuals with autism spectrum disorder. Georgiades S, Papageorgiou V, Anagnostou E, J Autism Dev Disord 2010 40 903 906 10.1007/s10803-009-0927-9 20108116
33. Factor analysis of repetitive behaviors in autism as measured by the Y-BOCS. Anagnostou E, Chaplin W, Watner D, Silverman JM, Smith CJ, Zagursky K, Kryzak LA, Corwin TE, Feirsen N, Tanel N, Hollander E, J Neuropsychiatry Clin Neurosci 2011 23 332 339 10.1176/appi.neuropsych.23.3.332 21948895
34. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Feifel D, Macdonald K, Nguyen A, Cobb P, Warlan H, Galangue B, Minassian A, Becker O, Cooper J, Perry W, Lefebvre M, Gonzales J, Hadley A, Biol Psychiatry 2010 68 678 680 10.1016/j.biopsych.2010.04.039 20615494
35. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Guastella AJ, Howard AL, Dadds MR, Mitchell P, Carson DS, Psychoneuroendocrinology 2009 34 917 923 10.1016/j.psyneuen.2009.01.005 19246160
36. Modulating social behavior with oxytocin: how does it work? What does it mean? Churchland PS, Winkielman P, Horm Behav 2012 61 392 399 10.1016/j.yhbeh.2011.12.003 22197271
37. Emotion recognition accuracy in healthy young females is associated with cycle phase. Derntl B, Kryspin-Exner I, Fernbach E, Moser E, Habel U, Horm Behav 2008 53 90 95 10.1016/j.yhbeh.2007.09.006 17976599
38. Sniffing neuropeptides: a transnasal approach to the human brain. Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL, Nat Neurosci 2002 5 514 516 10.1038/nn0602-849 11992114